• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

FDA approves Canadian firm's collagen-based wound-treatment dressing

Article

Mississauga, Ontario -- Covalon Technologies has received approval from the Food and Drug Administration for CovaClear Ag, a hydrated collagen dressing that contains antimicrobial silver.

Mississauga, Ontario - Covalon Technologies has received approval from the Food and Drug Administration for CovaClear Ag™, a hydrated collagen dressing that contains antimicrobial silver.

Officials of Mississauga-based Covalon Technologies said CovaClear Ag™ is the only hydrated collagen-based silver ion-releasing dressing on the market, and that the dressing provides a moist environment known to improve the wound-healing process and reduce scarring.

The officials said the silver ion is a broad-spectrum antiseptic that serves as an antimicrobial barrier, and that because the dressing is transparent, clinicians can monitor high-risk wounds without having to remove the dressing.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.